Your Top 100 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
LBA9 innovaTV 301/ENGOT-cx12/GOG-3057: A global, randomized, open-label, phase III study of tisotumab vedotin vs investigator’s choice of chemotherapy in 2L or 3L recurrent or metastatic cervical cancer
Ignace B. Vergote, Antonio González-Martı́n, Keiichi Fujiwara, Elsa Kalbacher, Andrea Bagaméri, Sharad A. Ghamande and 14 more
- Rank
- 97 of 3,639
- Percentile
- top 2.7%
- Where
- Annals of Oncology, 2023
- Citations
- 31
From the 2023 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.